Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
Keywords:
Immunotherapy
Interferon-gamma
PD-1
PD-L1
Lung cancer
Melanoma
Publisher:
SAGE Publications
Note:
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License
(http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission
provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Citation:
Karachaliou, N. (Niki); Gonzalez-Cao, M. (María); Crespo, G. (Guillermo); et al. "Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients". Therapeutic advances in medical oncology. 10, 2018, 1 - 23
Statistics and impact
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.